Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Neurochemistry|February 16, 2024
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathyEmma van den Berg, Iris Kersten, Gunnar Brinkmalm, et al.
Brain Communications|July 25, 2024
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PETSteffi De Meyer, Jolien M Schaeverbeke, Emma S Luckett, et al.
Brain Communications|February 24, 2023
Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 yearsAnouk den Braber, Inge M W Verberk, Jori Tomassen, et al.
Ebiomedicine|February 14, 2022
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's diseaseNicholas J Ashton, Andréa L Benedet, Tharick A Pascoal, et al.
Alzheimer'S Research & Therapy|September 29, 2020
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathologyInge M W Verberk, Elisabeth Thijssen, Jannet Koelewijn, et al.
Clinical Chemistry and Laboratory Medicine|October 27, 2015
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurementsMaria Bjerke, Ulf Andreasson, Julia Kuhlmann, et al.
Journal of Neurochemistry|August 21, 2018
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin studyBrit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, et al.
Npj Aging|September 4, 2023
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adultsJun Yuan, Steve Pedrini, Rohith Thota, et al.
EMBO Molecular Medicine|November 10, 2020
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detectedMarc Suárez-Calvet, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S Research & Therapy|April 23, 2024
Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid AngiopathyIngeborg Rasing, Sabine Voigt, Emma A Koemans, et al.
Pageof 6